Health-related Quality of Life, Fatigue, and Posttraumatic Growth of Cancer Patients Undergoing Radiation Therapy: A Longitudinal Study

被引:0
作者
Zsuzsanna Tanyi
Kornélia Szluha
László Nemes
Sándor Kovács
Antal Bugán
机构
[1] University of Debrecen,Department of Behavioural Sciences, Medical and Health Science Center
[2] University of Debrecen,Department of Radiotherapy, Medical and Health Science Center
[3] University of Debrecen,Department of Economic Analysis and Statistics, Institute of Economic Analytical Methodology and Applied Informatics
来源
Applied Research in Quality of Life | 2014年 / 9卷
关键词
Radiation therapy; Health-related quality of life; Fatigue; Posttraumatic growth;
D O I
暂无
中图分类号
学科分类号
摘要
The purpose of this study was to determine health-related quality of life (HRQoL), fatigue, and posttraumatic growth (PTG) among patients with breast or prostate cancer during and following radiation therapy (RT). A total of 91 patients completed measures at three time points as follows: one or two weeks before the start of RT, in the fifth/sixth week of treatment, and four to six weeks post-treatment. Consistent with the previous literature, the results of this study revealed that RT was associated with declines in global HRQoL, Physical Well-being, Social/Family Well-being, and Functional Well-being, as well as an increase in fatigue. By four to six weeks post-treatment, these factors improved significantly and returned to baseline levels with the exception of Social/Family Well-being. The PTG total score and almost all of its subscale scores did not change significantly during the period of the study. However, the subscale of Spiritual Change for PTG significantly increased during the RT, and sustained this improvement at four to six weeks post-treatment. A significant negative correlation was found between Physical Well-being and PTG total score, whereas a significant positive correlation was revealed between Social/Family Well-being and PTG total score. The results from this analysis suggest that a significant decrease in HRQoL is evident in the fifth/sixth week of RT treatment. However, recovery of HRQoL occurs as quickly as a few weeks after the end of treatment. Moreover, patients with high ratings of Social/Family Well-being experience more positive psychological changes (PTG) resulting from the cancer experience.
引用
收藏
页码:617 / 630
页数:13
相关论文
共 223 条
  • [1] Ahsberg E(2001)Dimensions of fatigue during radiotherapy. An application of the Swedish Occupational Fatigue Inventory (SOFI) on cancer patients Acta Oncologica 40 37-43
  • [2] Fürst CJ(2005)Absence of adverse early quality of life outcomes of radiation therapy in breast conservation therapy for early breast cancer Australasian Radiology 49 39-43
  • [3] Back M(2006)Posttraumatic growth in adolescent survivors of cancer and their mothers and fathers Journal of Pediatric Psychology 31 413-419
  • [4] Ahern V(2007)Positive and negative life changes experienced by survivors of Non-Hodgkin’s lymphoma Annals of Behavioral Medicine 34 188-199
  • [5] Delaney G(2005)Perceptions of positive meaning and vulnerability following breast cancer: Predictors and outcomes among long-term breast cancer survivors Annals of Behavioral Medicine 29 236-245
  • [6] Graham P(2004)Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis Health Psychology 23 595-598
  • [7] Steigler A(1993)The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure Journal of Clinical Oncology 11 570-579
  • [8] Wratten C(2005)A longitudinal prospective study of health-related quality of life in breast cancer patients following high-dose chemotherapy with autologous blood stem cell transplantation Bone Marrow Transplantation 36 251-259
  • [9] Barakat LP(2007)Breast cancer as trauma: Posttraumatic stress and posttraumatic growth Journal of Clinical Psychology in Medical Settings 14 308-319
  • [10] Alderfer MA(2007)Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy Annals of Oncology 18 940-944